Aktuelle Rheumatologie, ISSN 0341-051X, 10/2016, Volume 41, Issue 5, pp. 371 - 371
Journal Article
Gait & Posture, ISSN 0966-6362, 10/2018, Volume 66, pp. 247 - 254
Children suffering from juvenile idiopathic arthritis (JIA), a heterogeneous group of chronic inflammatory joint diseases, adapt to individual gait patterns to...
Plantar pressure analysis | 1D-SPM analysis | Three-dimensional gait analysis | Pedobarography | Juvenile idiopathic arthritis | SPORT SCIENCES | WALKING | PATTERNS | CLASSIFICATION | PARAMETERS | NEUROSCIENCES | INJECTIONS | ORTHOPEDICS | FOOT FUNCTION | Biomechanics | Walking | Arthritis | Analysis
Plantar pressure analysis | 1D-SPM analysis | Three-dimensional gait analysis | Pedobarography | Juvenile idiopathic arthritis | SPORT SCIENCES | WALKING | PATTERNS | CLASSIFICATION | PARAMETERS | NEUROSCIENCES | INJECTIONS | ORTHOPEDICS | FOOT FUNCTION | Biomechanics | Walking | Arthritis | Analysis
Journal Article
Padiatrische Praxis, ISSN 0030-9346, 2014, Volume 82, Issue 1, pp. 135 - 147
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2019
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2016, Volume 75, Issue 5, pp. 855 - 861
ImportancePublished evidence on the long-term safety of etanercept (ETA) and adalimumab (ADA) in patients with polyarticular juvenile idiopathic arthritis...
RHEUMATOID-ARTHRITIS | DMARDs (biologic) | CROHNS-DISEASE | ALPHA THERAPY | Juvenile Idiopathic Arthritis | FOLLOW-UP | Infections | OPEN-LABEL | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | Autoimmune Diseases | UVEITIS | Methotrexate | HEALTH ASSESSMENT QUESTIONNAIRE | Prospective Studies | Humans | Male | Opportunistic Infections - chemically induced | Adalimumab - adverse effects | Arthritis, Juvenile - drug therapy | Inflammatory Bowel Diseases - epidemiology | Neoplasms - chemically induced | Uveitis - epidemiology | Antirheumatic Agents - adverse effects | Biological Products - adverse effects | Female | Inflammatory Bowel Diseases - chemically induced | Registries | Arthritis, Juvenile - epidemiology | Child | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Etanercept - adverse effects | Opportunistic Infections - epidemiology | Germany - epidemiology | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adolescent | Autoimmune Diseases - chemically induced | Uveitis - chemically induced | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Etanercept - therapeutic use | Care and treatment | Dosage and administration | Etanercept | Adalimumab | Juvenile arthritis
RHEUMATOID-ARTHRITIS | DMARDs (biologic) | CROHNS-DISEASE | ALPHA THERAPY | Juvenile Idiopathic Arthritis | FOLLOW-UP | Infections | OPEN-LABEL | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | Autoimmune Diseases | UVEITIS | Methotrexate | HEALTH ASSESSMENT QUESTIONNAIRE | Prospective Studies | Humans | Male | Opportunistic Infections - chemically induced | Adalimumab - adverse effects | Arthritis, Juvenile - drug therapy | Inflammatory Bowel Diseases - epidemiology | Neoplasms - chemically induced | Uveitis - epidemiology | Antirheumatic Agents - adverse effects | Biological Products - adverse effects | Female | Inflammatory Bowel Diseases - chemically induced | Registries | Arthritis, Juvenile - epidemiology | Child | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Etanercept - adverse effects | Opportunistic Infections - epidemiology | Germany - epidemiology | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adolescent | Autoimmune Diseases - chemically induced | Uveitis - chemically induced | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Etanercept - therapeutic use | Care and treatment | Dosage and administration | Etanercept | Adalimumab | Juvenile arthritis
Journal Article
Rheumatology, ISSN 1462-0324, 05/2018, Volume 57, Issue 5, pp. 936 - 938
GENERALIZED PUSTULAR PSORIASIS | DITRA | RHEUMATOLOGY | Biomarkers - metabolism | Follow-Up Studies | Interleukin-17 - antagonists & inhibitors | Time Factors | Arthritis, Psoriatic - drug therapy | Humans | Antibodies, Monoclonal - therapeutic use | Arthritis, Psoriatic - diagnosis | Female | Interleukin-1 - antagonists & inhibitors | Interleukin-1 - deficiency | Child
Journal Article
Nature Genetics, ISSN 1061-4036, 06/2013, Volume 45, Issue 6, pp. 664 - 669
We used the Immunochip array to analyze 2,816 individuals with juvenile idiopathic arthritis (JIA), comprising the most common subtypes (oligoarticular and...
RHEUMATOID-ARTHRITIS | POPULATION | SYSTEMIC-LUPUS-ERYTHEMATOSUS | AUTOIMMUNE-DISEASES | PRIMARY BILIARY-CIRRHOSIS | GENETICS & HEREDITY | GENE-EXPRESSION | CCR5 GENE | COMMON | GENOME-WIDE ASSOCIATION | CELIAC-DISEASE | Genetic Predisposition to Disease | Genome-Wide Association Study | Gene Frequency | Humans | Molecular Sequence Annotation | Receptors, CCR - genetics | Risk Factors | Genotype | Chromosome Mapping | Genetic Loci | Arthritis, Juvenile - genetics | Receptors, Interleukin - genetics | Case-Control Studies | Linkage Disequilibrium | Interleukins - genetics | Arthritis, Juvenile - immunology | Adult | Polymorphism, Single Nucleotide | Child | Rheumatoid factor | Histocompatibility antigens | HLA histocompatibility antigens | Arthritis | Genetic aspects | Disease susceptibility | Research | Health aspects | Risk factors | Studies | Medical research | Genetics | Autoimmune diseases | Children & youth
RHEUMATOID-ARTHRITIS | POPULATION | SYSTEMIC-LUPUS-ERYTHEMATOSUS | AUTOIMMUNE-DISEASES | PRIMARY BILIARY-CIRRHOSIS | GENETICS & HEREDITY | GENE-EXPRESSION | CCR5 GENE | COMMON | GENOME-WIDE ASSOCIATION | CELIAC-DISEASE | Genetic Predisposition to Disease | Genome-Wide Association Study | Gene Frequency | Humans | Molecular Sequence Annotation | Receptors, CCR - genetics | Risk Factors | Genotype | Chromosome Mapping | Genetic Loci | Arthritis, Juvenile - genetics | Receptors, Interleukin - genetics | Case-Control Studies | Linkage Disequilibrium | Interleukins - genetics | Arthritis, Juvenile - immunology | Adult | Polymorphism, Single Nucleotide | Child | Rheumatoid factor | Histocompatibility antigens | HLA histocompatibility antigens | Arthritis | Genetic aspects | Disease susceptibility | Research | Health aspects | Risk factors | Studies | Medical research | Genetics | Autoimmune diseases | Children & youth
Journal Article
Trauma und Berufskrankheit, ISSN 1436-6274, 2/2016, Volume 18, Issue S2, pp. 117 - 121
Chronische Schmerzen treten bei Kindern und Jugendlichen zunehmend häufiger auf.Bei chronischen muskuloskeletalen Schmerzen kommen differenzialdiagnostisch...
Multimodal treatment | Posttraumatic pain | Medicine & Public Health | Jugendliche | Chronische Schmerzen | Traumatic Surgery | Multimodale Behandlung | Kinder | Posttraumatische Schmerzen | Children | Adolescents | Chronic pain
Multimodal treatment | Posttraumatic pain | Medicine & Public Health | Jugendliche | Chronische Schmerzen | Traumatic Surgery | Multimodale Behandlung | Kinder | Posttraumatische Schmerzen | Children | Adolescents | Chronic pain
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 06/2017, Volume 56, Issue 6, pp. 901 - 906
Objectives. A high proportion of children with JIA will develop intolerance to MTX with anticipatory and associative gastrointestinal adverse effects. Parents...
Countermeasures | Adverse effects | Methotrexate | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | countermeasures | adverse effects | ONDANSETRON | PREVENTION | methotrexate | ANTICIPATORY NAUSEA | PREVALENCE | RHEUMATOLOGY | juvenile idiopathic arthritis | CHEMOTHERAPY | CHILDREN | Prospective Studies | Gastrointestinal Diseases - prevention & control | Humans | Parents | Male | Arthritis, Juvenile - drug therapy | Methotrexate - adverse effects | Complementary Therapies | Antiemetics - therapeutic use | Treatment Failure | Antirheumatic Agents - adverse effects | Female | Taste | Child | Gastrointestinal Diseases - chemically induced
Countermeasures | Adverse effects | Methotrexate | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | countermeasures | adverse effects | ONDANSETRON | PREVENTION | methotrexate | ANTICIPATORY NAUSEA | PREVALENCE | RHEUMATOLOGY | juvenile idiopathic arthritis | CHEMOTHERAPY | CHILDREN | Prospective Studies | Gastrointestinal Diseases - prevention & control | Humans | Parents | Male | Arthritis, Juvenile - drug therapy | Methotrexate - adverse effects | Complementary Therapies | Antiemetics - therapeutic use | Treatment Failure | Antirheumatic Agents - adverse effects | Female | Taste | Child | Gastrointestinal Diseases - chemically induced
Journal Article
Trauma und Berufskrankheit, ISSN 1436-6274, 02/2016, Volume 18, Issue 1, p. 117
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10039-015-0058-9...
Care and treatment | Pain | Chronic pain
Care and treatment | Pain | Chronic pain
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 11/2016, Volume 18, Issue 1, p. 272
Background: Treatment response, remission rates and compliance in patients with polyarticular juvenile idiopathic arthritis (polyJIA) treated with adalimumab,...
Drug surveillance | Etanercept | Adalimumab | Tocilizumab | JADAS | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | SAFETY | METHOTREXATE | RHEUMATOLOGY | BIOLOGICS | CHILDREN | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | PEDIATRIC RHEUMATOLOGY | JIA REGISTRY | DISEASE-ACTIVITY SCORE | Medication Adherence - statistics & numerical data | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Male | Treatment Outcome | Remission Induction | Arthritis, Juvenile - drug therapy | Adalimumab - therapeutic use | Adolescent | Female | Registries | Child | Antirheumatic Agents - therapeutic use | Etanercept - therapeutic use | Juvenile arthritis | Research | Comparative analysis | Drug therapy | Patient compliance | Health aspects
Drug surveillance | Etanercept | Adalimumab | Tocilizumab | JADAS | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | SAFETY | METHOTREXATE | RHEUMATOLOGY | BIOLOGICS | CHILDREN | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | PEDIATRIC RHEUMATOLOGY | JIA REGISTRY | DISEASE-ACTIVITY SCORE | Medication Adherence - statistics & numerical data | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Male | Treatment Outcome | Remission Induction | Arthritis, Juvenile - drug therapy | Adalimumab - therapeutic use | Adolescent | Female | Registries | Child | Antirheumatic Agents - therapeutic use | Etanercept - therapeutic use | Juvenile arthritis | Research | Comparative analysis | Drug therapy | Patient compliance | Health aspects
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 03/2014, Volume 66, pp. S58 - S58
Background/Purpose: The outcome of children with JIA refractory to diseaseâmodifying antirheumatic drugs (DMARDs) has improved significantly since Etanercept...
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2015, Volume 112, Issue 52, pp. 15970 - 15975
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, p. e0153267
Objective Aims of the study were to investigate health-related quality of life (HRQOL) in adult patients with former diagnosis of Juvenile Idiopathic Arthritis...
RHEUMATOID-ARTHRITIS | MANAGEMENT | PREDICTORS | MULTIDISCIPLINARY SCIENCES | EQ-5D QUESTIONNAIRE | ADULTS | FOLLOW-UP | PREVALENCE | OUTCOMES | PEDIATRIC RHEUMATOLOGY | CHILDREN | Cross-Sectional Studies | Humans | Middle Aged | Logistic Models | Male | Arthritis, Juvenile - physiopathology | Young Adult | Adolescent | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Health Status | Germany | Cohort Studies | Care and treatment | Demographic aspects | Juvenile arthritis | Patient outcomes | Physiological aspects | Research | Quality of life | Adolescence | Demography | Identification methods | Population studies | Arthritis | Mental depression | Confidence intervals | Demographics | Regression models | Pain | Questionnaires | Anxiety | Teenagers | Diagnosis | Children | Adolescents | Age | Statistical analysis | Rheumatic diseases | Environmental health | Rheumatology | Regression analysis | Patients | Medicine | Studies | Psychological aspects | Hospitals | Rheumatoid arthritis
RHEUMATOID-ARTHRITIS | MANAGEMENT | PREDICTORS | MULTIDISCIPLINARY SCIENCES | EQ-5D QUESTIONNAIRE | ADULTS | FOLLOW-UP | PREVALENCE | OUTCOMES | PEDIATRIC RHEUMATOLOGY | CHILDREN | Cross-Sectional Studies | Humans | Middle Aged | Logistic Models | Male | Arthritis, Juvenile - physiopathology | Young Adult | Adolescent | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Health Status | Germany | Cohort Studies | Care and treatment | Demographic aspects | Juvenile arthritis | Patient outcomes | Physiological aspects | Research | Quality of life | Adolescence | Demography | Identification methods | Population studies | Arthritis | Mental depression | Confidence intervals | Demographics | Regression models | Pain | Questionnaires | Anxiety | Teenagers | Diagnosis | Children | Adolescents | Age | Statistical analysis | Rheumatic diseases | Environmental health | Rheumatology | Regression analysis | Patients | Medicine | Studies | Psychological aspects | Hospitals | Rheumatoid arthritis
Journal Article
IEEE Transactions on Neural Systems and Rehabilitation Engineering, ISSN 1534-4320, 03/2015, Volume 23, Issue 2, pp. 319 - 331
In clinical gait analysis, the gait of a patient is recorded with optical motion capture and compared with a healthy reference group. High-dimensional gait...
Pathology | Visualization | Hidden Markov models | Data models | Vectors | Indexes | statistical analysis | Joints | Motion analysis | MOTION | RECOGNITION | ENGINEERING, BIOMEDICAL | CLASSIFICATION | REHABILITATION | QUANTIFY NORMALITY | PART 2 | CEREBRAL-PALSY | CHILDREN | Physical Examination - standards | Markov Chains | Physical Examination - methods | Reproducibility of Results | Gait | Humans | Image Interpretation, Computer-Assisted - methods | Pattern Recognition, Automated - standards | Male | Reference Values | Whole Body Imaging - standards | Models, Statistical | Gait Disorders, Neurologic - diagnosis | Machine Learning | Algorithms | Computer Simulation | Gait Disorders, Neurologic - physiopathology | Sensitivity and Specificity | Adolescent | Female | Image Interpretation, Computer-Assisted - standards | Whole Body Imaging - methods | Child | Pattern Recognition, Automated - methods
Pathology | Visualization | Hidden Markov models | Data models | Vectors | Indexes | statistical analysis | Joints | Motion analysis | MOTION | RECOGNITION | ENGINEERING, BIOMEDICAL | CLASSIFICATION | REHABILITATION | QUANTIFY NORMALITY | PART 2 | CEREBRAL-PALSY | CHILDREN | Physical Examination - standards | Markov Chains | Physical Examination - methods | Reproducibility of Results | Gait | Humans | Image Interpretation, Computer-Assisted - methods | Pattern Recognition, Automated - standards | Male | Reference Values | Whole Body Imaging - standards | Models, Statistical | Gait Disorders, Neurologic - diagnosis | Machine Learning | Algorithms | Computer Simulation | Gait Disorders, Neurologic - physiopathology | Sensitivity and Specificity | Adolescent | Female | Image Interpretation, Computer-Assisted - standards | Whole Body Imaging - methods | Child | Pattern Recognition, Automated - methods
Journal Article
Physics Letters B, ISSN 0370-2693, 09/2018, Volume 784, Issue C, pp. 173 - 191
The observation of Higgs boson production in association with a top quark pair ( ), based on the analysis of protonâproton collision data at a centre-of-mass...
PHYSICS, NUCLEAR | SEARCH | ASTRONOMY & ASTROPHYSICS | PHYSICS, PARTICLES & FIELDS | Physics - High Energy Physics - Experiment | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
PHYSICS, NUCLEAR | SEARCH | ASTRONOMY & ASTROPHYSICS | PHYSICS, PARTICLES & FIELDS | Physics - High Energy Physics - Experiment | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Journal Article
Pediatric Rheumatology, ISSN 1546-0096, 09/2016, Volume 14, Issue 1, p. 52
High-dose intravenous immune globulins (IVIg) are frequently used in refractory juvenile dermatomyositis (JDM) but are often poorly tolerated. High-dose...
Juvenile dermatomyositis | Recombinant human hyaluronidase | Intravenous immune globulins | Subcutaneous immune globulins | Drug-Related Side Effects and Adverse Reactions - prevention & control | Humans | Immunoglobulins, Intravenous - adverse effects | Immunoglobulins, Intravenous - administration & dosage | Male | Recombinant Proteins - pharmacokinetics | Hyaluronoglucosaminidase - pharmacokinetics | Drug Monitoring - methods | Dermatomyositis - physiopathology | Dose-Response Relationship, Drug | Dermatomyositis - immunology | Dermatomyositis - drug therapy | Hyaluronoglucosaminidase - administration & dosage | Female | Child | Immunomodulation | Immunologic Factors - administration & dosage | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Recombinant Proteins - administration & dosage | Monitoring, Immunologic - methods | Cell Membrane Permeability - drug effects | Subcutaneous Tissue - immunology | Immunologic Factors - adverse effects | Subcutaneous Tissue - drug effects | Treatment outcome | Immunoglobulins | Safety and security measures | Analysis | Dermatomyositis | Dosage and administration | Drug therapy
Juvenile dermatomyositis | Recombinant human hyaluronidase | Intravenous immune globulins | Subcutaneous immune globulins | Drug-Related Side Effects and Adverse Reactions - prevention & control | Humans | Immunoglobulins, Intravenous - adverse effects | Immunoglobulins, Intravenous - administration & dosage | Male | Recombinant Proteins - pharmacokinetics | Hyaluronoglucosaminidase - pharmacokinetics | Drug Monitoring - methods | Dermatomyositis - physiopathology | Dose-Response Relationship, Drug | Dermatomyositis - immunology | Dermatomyositis - drug therapy | Hyaluronoglucosaminidase - administration & dosage | Female | Child | Immunomodulation | Immunologic Factors - administration & dosage | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Recombinant Proteins - administration & dosage | Monitoring, Immunologic - methods | Cell Membrane Permeability - drug effects | Subcutaneous Tissue - immunology | Immunologic Factors - adverse effects | Subcutaneous Tissue - drug effects | Treatment outcome | Immunoglobulins | Safety and security measures | Analysis | Dermatomyositis | Dosage and administration | Drug therapy
Journal Article